Creative Medical Health announced today filing of intellectual property covering the utilization of its proprietary mesenchymal stem cell-based product for treatment for autoimmune diseases, with multiple sclerosis being the first disease in which the product will be clinically assessed. The patent covers various modifications and cell types that are used to specifically stop the immunological processes that cause inflammation in the nervous system, which leads to the pathology seen in multiple sclerosis.
http://ift.tt/1BYyZNg
http://ift.tt/1BYyZNg
No comments:
Post a Comment